Donald Richards
Cedars-Sinai Medical Center(US)Pennsylvania State University(US)The University of Texas at Tyler(US)Texas Oncology(US)Sarah Cannon(US)Janssen (United States)(US)
Publications by Year
Research Areas
Colorectal Cancer Treatments and Studies, Lung Cancer Treatments and Mutations, Cancer Treatment and Pharmacology, Pancreatic and Hepatic Oncology Research, HER2/EGFR in Cancer Research
Most-Cited Works
- → Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): a global, randomised, open-label, phase 3 trial(2015)1,174 cited
- → Clinical validation of a targeted methylation-based multi-cancer early detection test using an independent validation set(2021)895 cited
- → Randomized, Controlled Trial of Irinotecan Plus Infusional, Bolus, or Oral Fluoropyrimidines in First-Line Treatment of Metastatic Colorectal Cancer: Results From the BICC-C Study(2007)854 cited
- → Pilot Study Using Molecular Profiling of Patients' Tumors to Find Potential Targets and Select Treatments for Their Refractory Cancers(2010)632 cited
- → Docetaxel With Cyclophosphamide Is Associated With an Overall Survival Benefit Compared With Doxorubicin and Cyclophosphamide: 7-Year Follow-Up of US Oncology Research Trial 9735(2009)585 cited